These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37796916)

  • 1. Mental Health Clinician Practices and Perspectives on Treating Adults with Co-Occurring Posttraumatic Stress and Substance Use Disorders.
    Vujanovic AA; Back SE; Leonard SJ; Zoller L; Kaysen DL; Norman SB; Flanagan JC; Schmitz JM; Resick P
    J Dual Diagn; 2023; 19(4):189-198. PubMed ID: 37796916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological treatment of PTSD with comorbid substance use disorder (SUD): expert recommendations of the European Society for Traumatic Stress Studies (ESTSS).
    Roberts NP; Lotzin A; Schäfer I
    Eur J Psychotraumatol; 2023; 14(2):2265773. PubMed ID: 37830207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial.
    Kehle-Forbes SM; Nelson D; Norman SB; Schnurr PP; Shea MT; Ackland PE; Meis L; Possemato K; Polusny MA; Oslin D; Hamblen JL; Galovski T; Kenny M; Babajide N; Hagedorn H
    Contemp Clin Trials; 2022 Sep; 120():106876. PubMed ID: 35987487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating posttraumatic stress disorder in substance use disorder patients with co-occurring posttraumatic stress disorder: study protocol for a randomized controlled trial to compare the effectiveness of different types and timings of treatment.
    Lortye SA; Will JP; Marquenie LA; Goudriaan AE; Arntz A; de Waal MM
    BMC Psychiatry; 2021 Sep; 21(1):442. PubMed ID: 34493253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study design, interventions, and baseline characteristics for the Substance use and TRauma Intervention for VEterans (STRIVE) trial.
    Kehle-Forbes SM; Drapkin ML; Foa EB; Koffel E; Lynch KG; Polusny MA; Van Horn DH; Yusko DA; Charlesworth M; Blasco M; Oslin DW
    Contemp Clin Trials; 2016 Sep; 50():45-53. PubMed ID: 27444425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial.
    Vujanovic AA; Smith LJ; Green CE; Lane SD; Schmitz JM
    Contemp Clin Trials; 2018 Feb; 65():123-129. PubMed ID: 29287668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and acceptability of interventions for co-occurring PTSD and SUD: A meta-analysis.
    Simpson TL; Goldberg SB; Louden DKN; Blakey SM; Hawn SE; Lott A; Browne KC; Lehavot K; Kaysen D
    J Anxiety Disord; 2021 Dec; 84():102490. PubMed ID: 34763220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
    Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
    Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
    Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
    Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.
    Simpson TL; Lehavot K; Petrakis IL
    Alcohol Clin Exp Res; 2017 Apr; 41(4):681-702. PubMed ID: 28055143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective analysis of language use in cognitive-behavioral therapy: associations with symptom change in adults with co-occurring substance use disorders and posttraumatic stress.
    Jennings AN; Soder HE; Wardle MC; Schmitz JM; Vujanovic AA
    Cogn Behav Ther; 2021 Mar; 50(2):89-103. PubMed ID: 33021143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment.
    Brown DG; Flanagan JC; Jarnecke A; Killeen TK; Back SE
    J Ethn Subst Abuse; 2022; 21(3):1141-1164. PubMed ID: 33111647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.
    Hien DA; Campbell AN; Ruglass LM; Saavedra L; Mathews AG; Kiriakos G; Morgan-Lopez A
    J Subst Abuse Treat; 2015 Sep; 56():23-33. PubMed ID: 25907849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?
    Bountress KE; Badour C; Flanagan J; Gilmore AK; Back SE
    Psychol Trauma; 2018 Nov; 10(6):662-665. PubMed ID: 28771018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Treatment of Substance Use and PTSD.
    Flanagan JC; Korte KJ; Killeen TK; Back SE
    Curr Psychiatry Rep; 2016 Aug; 18(8):70. PubMed ID: 27278509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder.
    Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL
    Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments.
    Fitzpatrick S; Saraiya T; Lopez-Castro T; Ruglass LM; Hien D
    J Subst Abuse Treat; 2020 Jun; 113():107976. PubMed ID: 32059924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Lifetime Panic Attacks, Posttraumatic Stress Disorder, and Substance Use Disorders in a Nationally Representative Sample.
    Blakey SM; Campbell SB; Simpson TL
    J Dual Diagn; 2022; 18(1):21-32. PubMed ID: 34965200
    [No Abstract]   [Full Text] [Related]  

  • 19. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
    Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
    J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Exposure-Based Risk Reduction Through Family Therapy for Co-occurring Substance Use Problems and Posttraumatic Stress Disorder Symptoms Among Adolescents: A Randomized Clinical Trial.
    Danielson CK; Adams Z; McCart MR; Chapman JE; Sheidow AJ; Walker J; Smalling A; de Arellano MA
    JAMA Psychiatry; 2020 Jun; 77(6):574-586. PubMed ID: 32022827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.